June 6, 2017

Celldex Therapeutics to Participate in the Jefferies 2017 Global Healthcare Conference

HAMPTON, N.J., June 06, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Tibor Keler, Ph.D., Co-founder, Executive Vice President and Chief Scientific Officer, and Thomas Davis, M.D., Executive Vice President and Chief Medical Officer, will participate in a fireside chat at the Jefferies 2017 Global Healthcare Conference on June 8, 2017 at 11:00 a.m. EDT in New York.

The live webcast will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for seven days following the event.

About Celldex Therapeutics, Inc.

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes antibodies, antibody-drug conjugates and other protein-based therapeutics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Visit www.celldex.com.

Company Contact



Sarah Cavanaugh

Vice President of Investor Relations & Corp Communications

Celldex Therapeutics, Inc.

(781) 433-3161

scavanaugh@celldex.com



Charles Liles

Associate Director of Investor Relations & Corp Communications

Celldex Therapeutics, Inc.

(781) 433-3107

cliles@celldex.com

Primary Logo

Source: Celldex Therapeutics, Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2017 Celldex Therapeutics, Inc.